Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2007
05/02/2007EP1778705A1 Phosphonium ionic liquids as recyclable solvents for solution phase chemistry
05/02/2007EP1778704A1 Process for the preparation of asymmetrically substituted biaryldiphosphines
05/02/2007EP1778703A1 Coupling agents comprising a photolabile protecting group and uses thereof, such as for the functionalisation of solid supports
05/02/2007EP1778702A2 Antiviral compounds
05/02/2007EP1778699A2 Targeting chelants and chelates
05/02/2007EP1778252A2 Noncardiotoxic pharmaceutical compounds
05/02/2007EP1778250A2 Novel thiazole inhibitors of fructose 1,6-bisphosphatase
05/02/2007EP1778249A2 Nucleoside phosphonate conjugates as anti hiv agents
05/02/2007EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
05/02/2007EP1299342B1 Method for producing 3,3-diarylpropylamines
05/02/2007CN1957115A Method for electroplating bath chemistry control
05/02/2007CN1957001A Alkoxyamines containing a radically polymerizable group
05/02/2007CN1956780A Affinity particle and affinity separation method
05/02/2007CN1956779A Affinity particle and affinity separation method
05/02/2007CN1956723A Sulfonylethyl phosphorodiamidates
05/02/2007CN1955185A Optical active substitution oxyphosphonate salt acetate and its use
05/02/2007CN1955176A Optical separation method substituting oxyphosphonate acetate
05/02/2007CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
05/01/2007US7211705 Vinylaromatic copolymers in which the first styrene monomer is substituted with catalytically active functional groups and the second styrene monomer is substituted with lipophilic groups; polyisobutylene bound to a catalytically active group
05/01/2007US7211690 One-step process for making phosphonium haloalkylsulfonate antistatic agent by combining an alkyl sulfonate salt of lithium or Sodium with a tetraalkylphosphonium halogen in an aqueous medium; simple mixing of the reactants results in a precipitation of the anti-static molecule in high yield
05/01/2007US7211663 Antiinflammatory agents; immobilized on solid support
05/01/2007CA2282515C Process for the carbonylation of ethylene
05/01/2007CA2268434C Mycophenolic bisphosphonate derivatives and their preparation from tetraphosphonate bicyclic trisanhydrides
05/01/2007CA2155493C Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
05/01/2007CA2146203C Enhancement of the storage stability of organic phosphites and phosphonites
05/01/2007CA2132131C 3-arylbenzofuranones as stabilisers
04/2007
04/26/2007WO2007047315A1 Amifostine dihydrate crystalline composition
04/26/2007WO2007046729A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
04/26/2007WO2007045496A1 Novel urokinase inhibitors
04/26/2007US20070093454 sodium channel modulators, such as Isobutyl 4-(6-(2-hydroxyphenyl)pyrimidin-4-yl)piperazine-1-carboxylate, used as analgesics
04/26/2007DE102004063360B4 Bisphenyl-2,3,5,6-tetrafluor-4-trifluormethylphenylphosphinoxid-Derivat und dessen Synthese Bisphenyl-2,3,5,6-tetrafluoro-4-trifluormethylphenylphosphinoxid derivative and its synthesis
04/25/2007EP1777297A1 Fluorescent substrates for detecting organophosphatase enzyme activity
04/25/2007EP1478652B1 Components for producing amphoteric liposomes
04/25/2007EP1438132B1 Phosphonites used in catalyst systems for the addition of prussic acid to olefinic double bonds and for the isomerisation of organic nitriles
04/25/2007EP1305037B1 Analgesic medicament
04/25/2007CN1954079A Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same
04/25/2007CN1953986A Purification of N-(phosphonomethyl)glycine
04/25/2007CN1953985A Prodrugs of piperazine and substituted piperidine antiviral agents
04/25/2007CN1953953A Metal complex comprising beta-diketonato as ligand
04/25/2007CN1951946A Chiral monodentate phosphite ligands, its preparation method and uses
04/25/2007CN1951945A Phosphine-phosphoramidite ligand, its preparation method and uses
04/25/2007CN1951944A Dedevap continuous production method
04/25/2007CN1951903A Process for preparing 2-cyclohexenone compounds
04/25/2007CN1312163C Hydroxy ethylidene diphosphonic acid with content of greater than or equal to 90 percent and process for making same
04/25/2007CN1312162C Organic phosphine compound with both hole and electron channel structure and its oxide and prepn process
04/25/2007CN1312161C 3-hydroxy-4,3',4',5'-tetromethoxy bibenzyl phosphate and its composition, prepn and application
04/25/2007CN1312135C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
04/24/2007US7208633 Process for preparation of diphosphine compounds and intermediates for the process
04/24/2007US7208626 Reacting a (perfluoroalkyl)phosphorane fluoride with a hydride ion donor such as triethylsilane, tripropylsilane or sodium borohydride while refluxing
04/24/2007US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
04/24/2007US7208606 Using carbon monoxide and hydrogen in presence of phosphine-containing cobalt hydroformylation catalyst
04/24/2007US7208605 Functionalized ionic liquids, and methods of use thereof
04/24/2007US7208557 Functional monomers for molecular recognition and catalysis
04/24/2007US7208551 Ultraviolet radiation transparency and reflectance; satellites
04/24/2007US7208527 Potassium channel modulators
04/24/2007US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones
04/24/2007US7208481 Monitoring the protein concentration in plasma or tissues; treating atherosclerosis, Alzheimer's disease, macular degeneration, retinitis pigmentosa, stroke, degenerative neuropathy, multiple sclerosis, xanthoma, xanthelasma, cardiovascular disorder; tetramethyl N-(2-pyridyl)aminomethylenediphosphonate
04/24/2007US7208471 Glycopeptide phosphonate derivatives
04/24/2007US7208452 Process for manufacturing alkylphosphonate monoesters
04/24/2007US7208427 Precursor compositions and processes for MOCVD of barrier materials in semiconductor manufacturing
04/24/2007CA2337872C Cross-linked phenoxyphosphazene compound, process for producing the same, flame retardant, flame-retardant resin composition, and molded flame-retardant resin
04/24/2007CA2289472C Excitatory amino acid receptor modulators
04/24/2007CA2271892C Synthesis of ruthenium or osmium metathesis catalysts
04/24/2007CA2230517C Novel phosphino derivatives
04/24/2007CA2159776C Imidobisphosphoric acids, process for their preparation, and use thereof
04/19/2007WO2007044489A1 Flame retardant composition and method
04/19/2007WO2007044204A2 Propylene copolymer compositions
04/19/2007WO2007043450A1 Perfluoropolyether compound and lubricant and magnetic disk each containing or employing the same
04/19/2007WO2007043202A1 Stable novel nitron compound and use thereof
04/19/2007WO2007042431A1 Stabilization of polyolefins with liquid cyclic phosphites
04/19/2007WO2007042048A2 Method for preparing crystalline sodium risedronate
04/19/2007US20070088176 one-step, low cost, simple reaction with anhydrous hydrogen fluoride (HF), and converte into the corresponding phosphoranes by treatment with electrophilic reagents or Lewis acids; ionic liquid tributylethylphosphonium hexafluoroantimonate complexes with SbF5
04/19/2007US20070088166 Phosphine Ligand (L1c)(4-Di-tert-butylphosphanyl-1,5-diphenyl-1H-[1,2,3]triazole; forms complexes with transition metal; useful catalysts in coupling reactions such as Suzuki-Miyaura coupling, Stille coupling, Negishi coupling, Sonagashira coupling and hydrogenation
04/19/2007US20070088161 Novel chelated bisphosphonates for use as pharmaceutical agents
04/19/2007US20070088004 MAO-B inhibitors useful for treating obesity
04/19/2007US20070088002 Orally available sphingosine 1-phosphate receptor agonists and antagonists
04/19/2007US20070087446 Aromatic phosphonium salts and their use as labeling reagents in mass spectrometry analysis
04/19/2007DE102006013724B3 Polymer mass, useful to prepare molded article, films, fibers or shaped parts, comprises a polymer e.g. polyolefin and additive from phosphorus oxy compound
04/19/2007CA2625376A1 Stabilization of polyolefins with liquid cyclic phosphites
04/18/2007EP1775302A1 Method for preparing crystalline sodium risedronate
04/18/2007EP1775301A1 Novel supported phosphazene catalysts, novel compounds for the catalysts, and use thereof
04/18/2007EP1774331A2 Cytoxan antibodies and immunoassay
04/18/2007EP1773935A1 Phosphorus-containing flame retardant for thermoplastic polymers
04/18/2007EP1773853A1 Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts
04/18/2007EP1773852A1 Method for producing phosphate silanes
04/18/2007EP1773851A2 Improved method for making phosphoric acid
04/18/2007EP1773850A2 Prodrugs of hiv protease inhibitors
04/18/2007EP1773751A1 Process for preparing solid particles of phenolic antioxidants
04/18/2007EP1773750A1 Chemical compounds
04/18/2007EP1773740A1 Neurologically-active compounds
04/18/2007EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
04/18/2007EP1773352A2 Improved process for the preparation of oxidized phospholipids
04/18/2007EP1628778B1 Strongly adherent surface coatings
04/18/2007EP1425276B1 Heterocyclic carboxamides and their use as fungicides
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics
04/18/2007CN1951156A Organic electroluminescent element and manufacturing method thereof, organic compound containing phosphorous and manufacturing method thereof
04/18/2007CN1950436A Flame retardants
04/18/2007CN1950383A Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
04/18/2007CN1950344A Pharmaceutical compositions